Boustead Securities, LLC presents its latest Pre-IPO offering, Predictive Health Diagnostics.

Boustead Securities, LLC client Know Labs, Inc. announced that it intends to list on a major national exchange, either NASDAQ or the NYSE.

Acres “Cashless Casino” Technology $10M Pre-IPO Offering Now Live. Final Management Q&A Webinar This Thursday, February 11th at 12:30 PM PT.

PHD combines science, technology, proprietary analytics and clinical studies to detect cardiovascular disease and diabetes.

Boustead's client Chronix Biomedical, a molecular diagnostics company has entered into an agreement to be acquired, by Oncocyte Corporation.